| Molecular mechanisms linking oxidative stress and diabetes mellitus H Yaribeygi, T Sathyapalan, SL Atkin, A Sahebkar Oxidative medicine and cellular longevity 2020 (1), 8609213, 2020 | 563 | 2020 |
| A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial ES Kilpatrick, AS Rigby, SL Atkin Diabetes care 31 (11), 2198-2202, 2008 | 519 | 2008 |
| Insulin Resistance, the Metabolic Syndrome, and Complication Risk in Type 1 Diabetes: “Double diabetes” in the Diabetes Control and Complications Trial ES Kilpatrick, AS Rigby, SL Atkin Diabetes care 30 (3), 707-712, 2007 | 510 | 2007 |
| Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes V Jayagopal, P Albertazzi, ES Kilpatrick, EM Howarth, PE Jennings, ... Diabetes care 25 (10), 1709-1714, 2002 | 488 | 2002 |
| The effect of glucose variability on the risk of microvascular complications in type 1 diabetes ES Kilpatrick, AS Rigby, SL Atkin Diabetes care 29 (7), 1486-1490, 2006 | 464 | 2006 |
| Role of the NLRP3 inflammasome in cancer M Moossavi, N Parsamanesh, A Bahrami, SL Atkin, A Sahebkar Molecular cancer 17 (1), 158, 2018 | 394 | 2018 |
| Coexpression of estrogen receptor α and β: poor prognostic factors in human breast cancer? V Speirs, AT Parkes, MJ Kerin, DS Walton, PJ Carleton, JN Fox, SL Atkin Cancer research 59 (3), 525-528, 1999 | 378 | 1999 |
| Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone … JS Bevan, SL Atkin, AB Atkinson, PM Bouloux, F Hanna, PE Harris, ... The Journal of Clinical Endocrinology & Metabolism 87 (10), 4554-4563, 2002 | 365 | 2002 |
| Increased expression of estrogen receptor β mRNA in tamoxifen-resistant breast cancer patients V Speirs, C Malone, DS Walton, MJ Kerin, SL Atkin Cancer research 59 (21), 5421-5424, 1999 | 360 | 1999 |
| The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26 … L Meneghini, SL Atkin, SCL Gough, I Raz, L Blonde, M Shestakova, ... Diabetes care 36 (4), 858-864, 2013 | 339 | 2013 |
| Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial JR Petrie, N Chaturvedi, I Ford, MCGJ Brouwers, N Greenlaw, T Tillin, ... The lancet Diabetes & endocrinology 5 (8), 597-609, 2017 | 327 | 2017 |
| Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes ES Kilpatrick, AS Rigby, K Goode, SL Atkin Diabetologia 50, 2553-2561, 2007 | 280 | 2007 |
| Monocyte‐to‐HDL‐cholesterol ratio as a prognostic marker in cardiovascular diseases S Ganjali, AM Gotto Jr, M Ruscica, SL Atkin, AE Butler, M Banach, ... Journal of cellular physiology 233 (12), 9237-9246, 2018 | 276 | 2018 |
| The protective role of curcumin in myocardial ischemia–reperfusion injury A Mokhtari‐Zaer, N Marefati, SL Atkin, AE Butler, A Sahebkar Journal of cellular physiology 234 (1), 214-222, 2019 | 263 | 2019 |
| Efficacy and safety of liraglutide versus placebo as add-on to glucose-lowering therapy in patients with type 2 diabetes and moderate renal impairment (LIRA-RENAL): a … MJ Davies, SC Bain, SL Atkin, P Rossing, D Scott, MS Shamkhalova, ... Diabetes care 39 (2), 222-230, 2016 | 240 | 2016 |
| A review of the molecular mechanisms of hyperglycemia‐induced free radical generation leading to oxidative stress H Yaribeygi, SL Atkin, A Sahebkar Journal of cellular physiology 234 (2), 1300-1312, 2019 | 229 | 2019 |
| The regulation and importance of monocyte chemoattractant protein-1 V Bianconi, A Sahebkar, SL Atkin, M Pirro Current opinion in hematology 25 (1), 44-51, 2018 | 220 | 2018 |
| A phase 2, randomized, dose-finding study of the novel once-weekly human GLP-1 analog, semaglutide, compared with placebo and open-label liraglutide in patients with type 2 … MA Nauck, JR Petrie, G Sesti, E Mannucci, JP Courreges, ML Lindegaard, ... Diabetes care 39 (2), 231-241, 2016 | 220 | 2016 |
| High‐cocoa polyphenol‐rich chocolate improves HDL cholesterol in Type 2 diabetes patients DD Mellor, T Sathyapalan, ES Kilpatrick, S Beckett, SL Atkin Diabetic medicine 27 (11), 1318-1321, 2010 | 217 | 2010 |
| The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study P Costanzo, JGF Cleland, P Pellicori, AL Clark, D Hepburn, ES Kilpatrick, ... Annals of internal medicine 162 (9), 610-618, 2015 | 212 | 2015 |
Thozhukat SathyapalanProfessor of Endocrinology, Honorary Consultant Endocrinologist, University of Hull, UK在 hyms.ac.uk 的电子邮件经过验证
